Fingerprint
Dive into the research topics of 'A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932
Edith A. Perez, Vera J. Suman, Tom R. Fitch, James A. Mailliard, James N. Ingle, John T. Cole, Michael H. Veeder, Patrick J. Flynn, Daniel J. Walsh, Ferdinand K. Addo
Research output: Contribution to journal › Article › peer-review
16
Scopus
citations